In 18 consecutive aortic valvuloplasty patients at our institution, there have been no periprocedural deaths or vascular complications since we began to preclose with an 8F Prostar XL Perclose device.

ACC/AHA Guidelines: The Role of Percutaneous Balloon Aortic Valvuloplasty ...

and emergency balloon aortic valvuloplasty (eBAV) in CS patients. Methods A systematic literature review and meta-analysis was performed. The primary endpoint was mortality at 30 days. Secondary ...

med.ulaval.ca To be aware of the prevalence, pathophysiology and outcomes of mixed aortic valve disease (MAVD), which refers to combined aortic stenosis and aortic regurgitation. To assess the ...

Coronary artery disease (CAD) is present in 40–75% of patients undergoing transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis. Currently, the indication for TAVI is ...

1 Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan 2 Department of Advanced Cardiovascular Medicine, Tohoku University Graduate School of Medicine, ...

Transcatheter heart valve (THV) underexpansion after transcatheter aortic valve replacement may be associated with worse outcomes. THV expansion can be assessed fluoroscopically using a pigtail for ...

Objective: 3p deletion syndrome is a rare monosomal disease that encompasses deletions throughout the short arm of chromosome 3. It is often in the distal region (3p25-pter), but variations in ...